Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies

In an effort to promote higher quality patient care NCODA created the NCODA Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance resource for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI in Action is a follow up to the INQOVI® (decitabine and cedazuridine) PQI and explores how the medically integrated teams at Oncology Consultants and Virginia Cancer Institute incorporate PQIs as part of their daily workflow. It will discuss how utilizing the Oral Formulation of Decitabine and Cedazuridine (INQOVI®) for Hematological Malignancies PQI elevates patient care.